The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSE Regulatory News (SSE)

Share Price Information for SSE (SSE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,742.00
Bid: 1,740.50
Ask: 1,743.00
Change: 32.50 (1.90%)
Spread: 2.50 (0.144%)
Open: 1,732.50
High: 1,742.50
Low: 1,732.50
Prev. Close: 1,709.50
SSE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SSEN Transmission Appeals RIIOT2 to CMA

2 Mar 2021 14:00

RNS Number : 8776Q
SSE PLC
02 March 2021
 

SSE plc

SSEN Transmission appeals Ofgem's RIIO-T2 licence modification decision to the CMA

2 March 2021

SSEN Transmission, the owner of the electricity transmission network in the north of Scotland, can confirm that it intends to appeal certain elements of Ofgem's RIIO-T2 price control settlement to the Competition and Markets Authority (CMA). This follows the publication in December of Ofgem's Final Determinations for the RIIO-T2 period, which will operate from 1 April 2021 to 31 March 2026, and Ofgem's subsequent consultation on associated licence condition changes.

The appeal is both technical and narrow in scope, focussed on areas where Ofgem's decision does not reflect the robust evidence provided throughout the price control process, alongside material errors in the decision. These are:

· Cost of Equity which SSEN Transmission remains disappointed does not reflect market conditions and the robust evidence provided throughout the price control process.

· Outperformance wedge which goes against established regulatory practice by assuming, rather than incentivising, outperformance.

· New exposure to transmission charges which unfairly expose Transmission Owners to any under recovery of the NGESO's own revenue from the market (i.e. to Transmission Network Use of System charges that the NGESO is responsible to recover from users of the transmission system).

· Loss of appeals right for additional TOTEX released through Uncertainty Mechanisms and TOTEX adjustments made following an outputs assessment, which goes against established regulatory practice, creating unacceptable risk and precedent for future price controls.

SSEN Transmission has chosen not to appeal on the remaining elements of Ofgem's RIIO-T2 settlement (e.g. TOTEX or specific projects) and looks forward to working constructively with Ofgem to deliver its stakeholder-led business plan 'A Network for Net Zero'.

Subject to the CMA granting permission to appeal, the process is expected to take until the Autumn to reach a conclusion.

Commenting on the appeal, Rob McDonald, Managing Director of SSEN Transmission, said:

"Our appeal raises technical but very important issues that we are asking the CMA to correct. In the meantime, we can start to deliver against our stakeholder-led business plan and build our network for net zero, supporting government climate change targets and the green recovery from the coronavirus pandemic.

"We would like to thank Ofgem for its constructive engagement following publication of its Draft Determinations, and while it is regrettable we have been unable to reach agreement on all aspects of the final price control settlement, we will continue to work constructively with Ofgem and all stakeholders as the CMA considers the merits of our appeal."

Notes to Editors:

· SSEN Transmission, operating under licence held by Scottish Hydro Electric (SHE) Transmission plc, owns, operates and develops the high voltage electricity transmission system in the north of Scotland.

· SSEN Transmission is the wholly owned subsidiary of SSE plc.

ENQUIRIES

Investors and Analysts ir@sse.com +44(0)345 0760 530

Media media@sse.com +44(0)345 0760 530

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAFDAEANFEFA
Date   Source Headline
1st May 20247:00 amRNSTotal Voting Rights
10th Apr 20244:22 pmRNSDirector/PDMR Shareholding
9th Apr 20242:31 pmRNSDirector/PDMR Shareholding
2nd Apr 20249:37 amRNSTotal Voting Rights
27th Mar 20247:00 amRNSNotification of Closed Period
19th Mar 202411:00 amRNSSSEN Transmission welcomes ‘Beyond 2030’ plan
19th Mar 20247:01 amRNSDirector Declaration
12th Mar 20241:25 pmRNSDirector/PDMR Shareholding
11th Mar 20241:07 pmRNSDirector/PDMR Shareholding
11th Mar 20241:07 pmRNSDirector/PDMR Shareholding
1st Mar 20241:53 pmRNSAdditional Listing
1st Mar 20247:00 amRNSTotal Voting Rights
29th Feb 20242:55 pmRNSBlock Listing Six Monthly Return
14th Feb 20241:34 pmRNSScrip Alternative
8th Feb 20247:00 amRNSQ3 Trading Statement
7th Feb 20244:53 pmRNSDirector/PDMR Shareholding
1st Feb 20243:06 pmRNSTotal Voting Rights
18th Jan 202412:30 pmRNSScrip Alternative
17th Jan 20242:40 pmRNSHolding(s) in Company
10th Jan 20244:21 pmRNSHolding(s) in Company
9th Jan 202412:34 pmRNSSSEN TRANSMISSION BOND - CORRECTION
9th Jan 20249:01 amRNSSSEN TRANSMISSION ISSUES NEW £500m GREEN BOND
9th Jan 20248:56 amRNSDirector/PDMR Shareholding
2nd Jan 20247:00 amRNSDirector/PDMR Shareholding
2nd Jan 20247:00 amRNSTotal Voting Rights
27th Dec 202312:57 pmRNSDirector/PDMR Shareholding
18th Dec 20237:00 amRNSChange of Registrar
11th Dec 20234:00 pmRNSDirector/PDMR Shareholding
1st Dec 20231:59 pmRNSTotal Voting Rights
30th Nov 20233:33 pmRNSDirector/PDMR Shareholding
29th Nov 20233:59 pmRNSDirector/PDMR Shareholding
16th Nov 20232:11 pmRNSInterim Dividend Timetable
15th Nov 20237:00 amRNSHalf-year Report
9th Nov 20233:21 pmRNSDirector/PDMR Shareholding
1st Nov 202310:46 amRNSTotal Voting Rights
11th Oct 20232:15 pmRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNSNotification of Closed Period
3rd Oct 20233:55 pmRNSDirector/PDMR Shareholding
3rd Oct 20231:10 pmRNSDirectorate Change
2nd Oct 202311:14 amRNSTotal Voting Rights
27th Sep 20234:35 pmRNSDirector/PDMR Shareholding
22nd Sep 20232:08 pmRNSDirector/PDMR Shareholding
12th Sep 202310:49 amRNSAdditional Listing
11th Sep 20233:18 pmRNSDirector/PDMR Shareholding
8th Sep 20238:35 amRNSUK Contracts for Difference Allocation Round 5
1st Sep 20237:00 amRNSBlock Listing Six Monthly Return
1st Sep 20237:00 amRNSTotal Voting Rights
29th Aug 20234:53 pmRNSScrip Alternative
29th Aug 20234:45 pmRNSSSE Issues Eur750m Green Bond
25th Aug 202312:53 pmRNSPublication of Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.